-
What's Going On With Novavax Stock Today?
Monday, January 9, 2023 - 11:26am | 320Read More...Novavax Inc (NASDAQ: NVAX) shares are trading higher Monday after the company announced a CEO transition. What Happened: Novavax said John Jacobs will succeed Stanley Erck as president and CEO, as well as a member of the company's board of directors,...
-
Why Novavax Shares Are Rising Today
Monday, December 13, 2021 - 9:52am | 316Read More...Novavax Inc (NASDAQ: NVAX) is trading higher Monday after the company announced it filed for emergency use of its COVID-19 vaccine in the United Arab Emirates. Novavax submitted NVX-CoV2373, the company's recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M ...
-
Novavax CEO Talks $1.6B Federal Funding Win, Ex-FDA Chief Says It's A 'Good Bet'
Tuesday, July 7, 2020 - 11:48am | 466Read More...The U.S. government awarded Novavax, Inc. (NASDAQ: NVAX) $1.6 billion in funding to support its COVID-19 vaccine, and the company is confident it has the capability to produce 100 million doses by the end of the year, Novavax CEO Stanley Erck said on CNBC's "Squawk Box." Novavax...
-
Novavax Gets FDA's Fast Track Designation For Its RSV Vaccine For Older Adults
Wednesday, May 25, 2016 - 9:09am | 340Read More...Novavax, Inc. (NASDAQ: NVAX), a clinical-stage vaccine company, revealed Wednesday that the U.S. Food and Drug Administration has granted Fast Track Designation to its RSV F-Protein nanoparticle vaccine candidate (RSV F Vaccine) for the protection of older adults. According to the company, an...
-
Novavax CEO To Jim Cramer: 'We Are In For An Exciting Year'
Wednesday, January 13, 2016 - 11:11am | 209Read More...Novavax, Inc. (NASDAQ: NVAX) CEO Stanley Erck was a guest on Jim Cramer's "Mad Money" segment on Tuesday. Novavax is a clinical stage-vaccine company that targets known and newly emerging diseases. Its stock has lost around 20 percent since the start of 2016 more than 50 percent...
